Development of an anitsense-mediated exon skipping therapy for
Duchenne Muscular Dystrophy.
Aartsma-Rus, A.M.
Citation
Aartsma-Rus, A. M. (2005, February 10). Development of an anitsense-mediated exon
skipping therapy for Duchenne Muscular Dystrophy. Retrieved from
https://hdl.handle.net/1887/604
Version:
Corrected Publisher’s Version
References
Aartsma-Rus A, Bremmer-Bout M, Janson A, den Dunnen J, van Ommen G, van Deutekom J (2002) Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy. Neuromuscul Disord 12:S71.
Aartsma-Rus A, Janson AA, Kaman W E, Bremmer-Bout M, Den Dunnen JT, Baas F, Van Ommen GJ, et al (2003) Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients. Hum Mol Genet 12:907-14.
Aartsma-Rus A, Janson AA, Kaman W E, Bremmer-Bout M, Van Ommen GJ, Den Dunnen JT, Van Deutekom JC (2004a) Antisense-induced multiexon skipping for duchenne muscular dystrophy makes more sense. Am J Hum Genet 74:83-92.
Aartsma-Rus AK, W . E.; Bremmer-Bout, M.; Janson, A.; Den Dunnen, J.T.; van Ommen, G-J.B.; van Deutekom, J.C.T. (2004b) Comparative analysis of antisense oligonucleotide analogs for tageted DMD exon 46 skipping in muscle cells. Gene Therapy:
Achsel T, Shimura Y (1996) Factors involved in the activation of pre-mRNA splicing from downstream splicing enhancers. J Biochem (Tokyo) 120:53-60.
Acsadi G, Dickson G, Love DR, Jani A, W alsh FS, Gurusinghe A, W olff JA, et al (1991) Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature 352:815-8.
Acsadi G, Jani A, Massie B, Simoneau M, Holland P, Blaschuk K, Karpati G (1994) A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum Mol Genet 3:579-84.
Adcock IM, Caramori G (2001) Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol Cell Biol 79:376-84.
Ahmad A, Brinson M, Hodges BL, Chamberlain JS, Amalfitano A (2000) Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy. Hum Mol Genet 9:2507-15.
Ahn AH, Freener CA, Gussoni E, Yoshida M, Ozawa E, Kunkel LM (1996) The three human syntrophin genes are expressed in diverse tissues, have distinct chromosomal locations, and each bind to dystrophin and its relatives. J Biol Chem 271:2724-30.
Ahn AH, Kunkel LM (1993) The structural and functional diversity of dystrophin. Nat Genet 3:283-91
Ahn AH, Kunkel LM (1995) Syntrophin binds to an alternatively spliced exon of dystrophin. J Cell Biol 128:363-71. Ahn AH, Yoshida M, Anderson MS, Feener CA, Selig S, Hagiwara Y, Ozawa E, et al (1994) Cloning of human basic A1,
a distinct 59-kDa dystrophin-associated protein encoded on chromosome 8q 23-24. Proc Natl Acad Sci U S A 91:4446-50.
Aihara H, Miyazaki J (1998) Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 16:867-70. Akhtar S, Agrawal S (1997) In vivo studies with antisense oligonucleotides. Trends Pharmacol Sci 18:12-8
Akkaraju GR, Huard J, Hoffman EP, Goins W F, Pruchnic R, W atkins SC, Cohen JB, et al (1999) Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle. J Gene Med 1:280-9.
Alderton JM, Steinhardt RA (2000) Calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. J Biol Chem 275:9452-60.
Amalfitano A, Hauser MA, Hu H, Serra D, Begy CR, Chamberlain JS (1998) Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted. J Virol 72:926-33.
Angelini C, Fanin M, Pegoraro E, Freda MP, Cadaldini M, Martinello F (1994) Clinical-molecular correlation in 104 mild X-linked muscular dystrophy patients: characterization of sub-clinical phenotypes. Neuromuscul Disord 4:349-58.
Arahata K, Ishiura S, Ishiguro T, Tsukahara T, Suhara Y, Eguchi C, Ishihara T, et al (1988) Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature 333:861-3.
Araishi K, Sasaoka T, Imamura M, Noguchi S, Hama H, W akabayashi E, Yoshida M, et al (1999) Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice. Hum Mol Genet 8:1589-98.
Araki E, Nakamura K, Nakao K, Kameya S, Kobayashi O, Nonaka I, Kobayashi T, et al (1997) Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy. Biochem Biophys Res Commun 238:492-7.
Arikawa-Hirasawa E, Koga R, Tsukahara T, Nonaka I, Mitsudome A, Goto K, Beggs AH, et al (1995) A severe muscular dystrophy patient with an internally deleted very short (110 kD) dystrophin: presence of the binding site for dystrophin-associated glycoprotein (DAG) may not be enough for physiological function of dystrophin. Neuromuscul Disord 5:429-38.
Arzumanov A, Walsh AP, Rajwanshi VK, Kumar R, Wengel J, Gait MJ (2001) Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides. Biochemistry 40:14645-54. Audouy S, Molema G, de Leij L, Hoekstra D (2000) Serum as a modulator of lipoplex-mediated gene transfection:
dependence of amphiphile, cell type and complex stability. J Gene Med 2:465-76.
Austin RC, Morris GE, Howard PL, Klamut HJ, Ray PN (2000) Expression and synthesis of alternatively spliced variants of Dp71 in adult human brain. Neuromuscul Disord 10:187-93.
Badalamente MA, Stracher A (2000) Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition. Muscle Nerve 23:106-11.
Baker BF, Lot SS, Condon TP, Cheng-Flournoy S, Lesnik EA, Sasmor HM, Bennett CF (1997) 2'-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. J Biol Chem 272:11994-2000.
Baker BF, Monia BP (1999) Novel mechanisms for antisense-mediated regulation of gene expression. Biochim Biophys Acta 1489:3-18.
Bakker E, Hofker MH, Goor N, Mandel JL, Wrogemann K, Davies KE, Kunkel LM, et al (1985) Prenatal diagnosis and carrier detection of Duchenne muscular dystrophy with closely linked RFLPs. Lancet 1:655-8.
Bakker E, Van Broeckhoven C, Bonten EJ, van de Vooren MJ, Veenema H, Van Hul W, Van Ommen GJ, et al (1987) Germline mosaicism and Duchenne muscular dystrophy mutations. Nature 329:554-6.
Barbieri AM, Soriani N, Ferlini A, Michelato A, Ferrari M, Carrera P (1996) Seven novel additional small mutations and a new alternative splicing in the human dystrophin gene detected by heteroduplex analysis and restricted RT-PCR heteroduplex analysis of illegitimate transcripts. Eur J Hum Genet 4:183-7.
Bardoni A, Felisari G, Sironi M, Comi G, Lai M, Robotti M, Bresolin N (2000) Loss of Dp140 regulatory sequences is associated with cognitive impairment in dystrophinopathies. Neuromuscul Disord 10:194-9.
Barnea E, Zuk D, Simantov R, Nudel U, Yaffe D (1990) Specificity of expression of the muscle and brain dystrophin gene promoters in muscle and brain cells. Neuron 5:881-8.
Barry MA, Dower WJ, Johnston SA (1996) Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nat Med 2:299-305.
Bartlett RJ, Stockinger S, Denis MM, Bartlett WT, Inverardi L, Le TT, thi Man N, et al (2000) In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide. Nat Biotechnol 18:615-22
Barton ER (2003) Constituents of gentamicin promote nonsense suppression and restoration of dystrophin function in mdx mice European Muscle Conference "a link between fundamental research and therapeutic trials, Montpellier (France)
Barton-Davis ER, Cordier L, Shoturma DI, Leland SE, Sweeney HL (1999) Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J Clin Invest 104:375-81.
Bastianutto C, Bestard JA, Lahnakoski K, Broere D, De Visser M, Zaccolo M, Pozzan T, et al (2001) Dystrophin muscle enhancer 1 is implicated in the activation of non-muscle isoforms in the skeletal muscle of patients with X-linked dilated cardiomyopathy. Hum Mol Genet 10:2627-35.
Baumbach LL, Chamberlain JS, Ward PA, Farwell NJ, Caskey CT (1989) Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies. Neurology 39:465-74.
Beggs AH, Hoffman EP, Snyder JR, Arahata K, Specht L, Shapiro F, Angelini C, et al (1991) Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am J Hum Genet 49:54-67.
Beggs AH, Koenig M, Boyce FM, Kunkel LM (1990) Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet 86:45-8.
Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, Heimerikx M, Kerkhoven RM, et al (2004) A large-scale RNAi screen in human cells identifies new components of the p53 pathway; stable suppression of
tumorigenicity by virus-mediated RNA interference. Nature 428:431-7.
Bertoni C, Lau C, Rando TA (2003) Restoration of dystrophin expression in mdx muscle cells by chimeraplast-mediated exon skipping. Hum Mol Genet 12:1087-99.
Bertoni C, Rando TA (2002) Dystrophin gene repair in mdx muscle precursor cells in vitro and in vivo mediated by RNA-DNA chimeric oligonucleotides. Hum Gene Ther 13:707-18.
Bertorini TE, Palmieri GM, Griffin J, Igarashi M, Hinton A, Karas JG (1991) Effect of dantrolene in Duchenne muscular dystrophy. Muscle Nerve 14:503-7.
Bhatt DL, Gaylor DC, Lee RC (1990) Rhabdomyolysis due to pulsed electric fields. Plast Reconstr Surg 86:1-11. Bies RD, Caskey CT, Fenwick R (1992) An intact cysteine-rich domain is required for dystrophin function. J Clin Invest
90:666-72.
Blake DJ, Love DR, Tinsley J, Morris GE, Turley H, Gatter K, Dickson G, et al (1992) Characterization of a 4.8kb transcript from the Duchenne muscular dystrophy locus expressed in Schwannoma cells. Hum Mol Genet 1:103-9.
Blake DJ, Nawrotzki R, Loh NY, Gorecki DC, Davies KE (1998) beta-dystrobrevin, a member of the dystrophin-related protein family. Proc Natl Acad Sci U S A 95:241-6.
Blake DJ, Nawrotzki R, Peters MF, Froehner SC, Davies KE (1996) Isoform diversity of dystrobrevin, the murine 87-kDa postsynaptic protein. J Biol Chem 271:7802-10.
Blake DJ, Weir A, Newey SE, Davies KE (2002) Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 82:291-329.
Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, Ahima RS, Khurana TS (2002) Functional improvement of dystrophic muscle by myostatin blockade. Nature 420:418-21.
Bond UM, Yario TA, Steitz JA (1991) Multiple processing-defective mutations in a mammalian histone pre-mRNA are suppressed by compensatory changes in U7 RNA both in vivo and in vitro. Genes Dev 5:1709-22. Bonilla E, Samitt CE, Miranda AF, Hays AP, Salviati G, DiMauro S, Kunkel LM, et al (1988) Duchenne muscular
dystrophy: deficiency of dystrophin at the muscle cell surface. Cell 54:447-52.
Bonnemann CG, Modi R, Noguchi S, Mizuno Y, Yoshida M, Gussoni E, McNally EM, et al (1995) Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet 11:266-73.
Boyce FM, Beggs AH, Feener C, Kunkel LM (1991) Dystrophin is transcribed in brain from a distant upstream promoter. Proc Natl Acad Sci U S A 88:1276-80.
Braasch DA, Corey DR (2002a) Novel antisense and peptide nucleic acid strategies for controlling gene expression. Biochemistry 41:4503-10.
Braasch DA, Liu Y, Corey DR (2002b) Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design. Nucleic Acids Res 30:5160-7. Braun S, Thioudellet C, Rodriguez P, Ali-Hadji D, Perraud F, Accart N, Balloul JM, et al (2000) Immune rejection of
human dystrophin following intramuscular injections of naked DNA in mdx mice. Gene Ther 7:1447-57. Bremmer-Bout MA-R, A.; de Meijer, E.J.; Kaman, W. E.; Janson, A.A.M.; Vossen, R.; van Ommen, G.; den Dunnen, J.;
van Deutekom, J. (2004) Targeted Exon Skipping in Transgenic hDMD Mice: a Model for Direct Pre-clinical Screening of Human-specific Antisense Oligonucleotides. Molecular Therapy:
Brenman JE, Chao DS, Gee SH, McGee AW, Craven SE, Santillano DR, Wu Z, et al (1996) Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. Cell 84:757-67.
Brenman JE, Chao DS, Xia H, Aldape K, Bredt DS (1995) Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82:743-52.
Brockington M, Blake DJ, Prandini P, Brown SC, Torelli S, Benson MA, Ponting CP, et al (2001a) Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet 69:1198-209. Brockington M, Yuva Y, Prandini P, Brown SC, Torelli S, Benson MA, Herrmann R, et al (2001b) Mutations in the
fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet 10:2851-9.
Brown DA, Kang SH, Gryaznov SM, DeDionisio L, Heidenreich O, Sullivan S, Xu X, et al (1994) Effect of
phosphorothioate modification of oligodeoxynucleotides on specific protein binding. J Biol Chem 269:26801-5.
Brummelkamp TR, Bernards R, Agami R (2002) Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2:243-7.
Brun C, Suter D, Pauli C, Dunant P, Lochmuller H, Burgunder JM, Schumperli D, et al (2003) U7 snRNAs induce correction of mutated dystrophin pre-mRNA by exon skipping. Cell Mol Life Sci 60:557-66.
Buckle VJ, Guenet JL, Simon-Chazottes D, Love DR, Davies KE (1990) Localisation of a dystrophin-related autosomal gene to 6q24 in man, and to mouse chromosome 10 in the region of the dystrophia muscularis (dy) locus. Hum Genet 85:324-6.
Budker V, Zhang G, Danko I, Williams P, Wolff J (1998) The efficient expression of intravascularly delivered DNA in rat muscle. Gene Ther 5:272-6.
Bujold M, Caron N, Camiran G, Mukherjee S, Allen PD, Tremblay JP, Wang Y (2002) Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an HSV-1 amplicon vector. Cell Transplant 11:759-67.
Burke JF, Mogg AE (1985) Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G-418 and paromomycin. Nucleic Acids Res 13:6265-72.
Burkin DJ, Wallace GQ , Nicol KJ, Kaufman DJ, Kaufman SJ (2001) Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice. J Cell Biol 152:1207-18.
Burton EA, Tinsley JM, Holzfeind PJ, Rodrigues NR, Davies KE (1999) A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 96:14025-30.
Bushby KM, Appleton R, Anderson LV, Welch JL, Kelly P, Gardner-Medwin D (1995) Deletion status and intellectual impairment in Duchenne muscular dystrophy. Dev Med Child Neurol 37:260-9.
Byers TJ, Lidov HG, Kunkel LM (1993) An alternative dystrophin transcript specific to peripheral nerve. Nat Genet 4:77-81.
Campbell JM, Bacon TA, Wickstrom E (1990) Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid. J Biochem Biophys Methods 20:259-67.
Carlson BM (1973) The regeneration of skeletal muscle. A review. Am J Anat 137:119-49.
Cartegni L, Chew SL, Krainer AR (2002a) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3:285-98.
Cartegni L, Krainer AR (2002b) Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 30:377-84.
Cartegni L, Krainer AR (2003a) Correction of disease-associated exon skipping by synthetic exon-specific activators. Nat Struct Biol 10:120-5.
Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR (2003b) ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res 31:3568-71.
Cerletti M, Negri T, Cozzi F, Colpo R, Andreetta F, Croci D, Davies KE, et al (2003) Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer. Gene Ther 10:750-7. Chamberlain JS, Gibbs RA, Ranier JE, Nguyen PN, Caskey CT (1988) Deletion screening of the Duchenne muscular
dystrophy locus via multiplex DNA amplification. Nucleic Acids Res 16:11141-56.
Chapman VM, Miller DR, Armstrong D, Caskey CT (1989) Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice. Proc Natl Acad Sci U S A 86:1292-6.
Chaubourt E, Fossier P, Baux G, Leprince C, Israel M, De La Porte S (1999) Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy. Neurobiol Dis 6:499-507.
Chavany C, Saison-Behmoaras T, Le Doan T, Puisieux F, Couvreur P, Helene C (1994) Adsorption of oligonucleotides onto polyisohexylcyanoacrylate nanoparticles protects them against nucleases and increases their cellular uptake. Pharm Res 11:1370-8.
Chelly J, Gilgenkrantz H, Lambert M, Hamard G, Chafey P, Recan D, Katz P, et al (1990a) Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies. Cell 63:1239-48. Chelly J, Hamard G, Koulakoff A, Kaplan JC, Kahn A, Berwald-Netter Y (1990b) Dystrophin gene transcribed from
different promoters in neuronal and glial cells. Nature 344:64-5.
Chen CD, Kobayashi R, Helfman DM (1999) Binding of hnRNP H to an exonic splicing silencer is involved in the regulation of alternative splicing of the rat beta-tropomyosin gene. Genes Dev 13:593-606.
Chen YW, Zhao P, Borup R, Hoffman EP (2000) Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Biol 151:1321-36.
Chu G (1997) Double strand break repair. J Biol Chem 272:24097-100.
Clemens PR, Kochanek S, Sunada Y, Chan S, Chen HH, Campbell KP, Caskey CT (1996) In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes. Gene Ther 3:965-72
Cole-Strauss A, Yoon K, Xiang Y, Byrne BC, Rice MC, Gryn J, Holloman WK, et al (1996) Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide. Science 273:1386-9.
Collins L, Fabre JW (2004) A synthetic peptide vector system for optimal gene delivery to corneal endothelium. J Gene Med 6:185-94.
Comi GP, Ciafaloni E, de Silva HA, Prelle A, Bardoni A, Rigoletto C, Robotti M, et al (1995) A G+1-->A transversion at the 5' splice site of intron 69 of the dystrophin gene causing the absence of peripheral nerve Dp116 and severe clinical involvement in a DMD patient. Hum Mol Genet 4:2171-4.
Cossu G, Molinaro M, Pacifici M (1983) Differential response of satellite cells and embryonic myoblasts to a tumor promoter. Dev Biol 98:520-4.
Coulter LR, Landree MA, Cooper TA (1997) Identification of a new class of exonic splicing enhancers by in vivo selection. Mol Cell Biol 17:2143-50.
Cox GA, Cole NM, Matsumura K, Phelps SF, Hauschka SD, Campbell KP, Faulkner JA, et al (1993a) Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature 364:725-9. Cox GA, Phelps SF, Chapman VM, Chamberlain JS (1993b) New mdx mutation disrupts expression of muscle and
nonmuscle isoforms of dystrophin. Nat Genet 4:87-93.
Cox GA, Sunada Y, Campbell KP, Chamberlain JS (1994) Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy. Nat Genet 8:333-9.
Crooke ST (2000) Progress in antisense technology: the end of the beginning. Methods Enzymol 313:3-45.
Dash PR, Read ML, Barrett LB, Wolfert MA, Seymour LW (1999) Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. Gene Ther 6:643-50.
Davies K (2003) Utrophin and muscular dystrophy European Muscle Conference "a link between fundamental research and therapeutic trials", Montpellier (France)
Davies KE, Pearson PL, Harper PS, Murray JM, O'Brien T, Sarfarazi M, Williamson R (1983) Linkage analysis of two cloned DNA sequences flanking the Duchenne muscular dystrophy locus on the short arm of the human X chromosome. Nucleic Acids Res 11:2303-12.
Davies KE, Smith TJ, Bundey S, Read AP, Flint T, Bell M, Speer A (1988) Mild and severe muscular dystrophy associated with deletions in Xp21 of the human X chromosome. J Med Genet 25:9-13.
Davis HL, Demeneix BA, Quantin B, Coulombe J, Whalen RG (1993) Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum Gene Ther 4:733-40.
De Angelis FG, Sthandier O, Berarducci B, Toso S, Galluzzi G, Ricci E, Cossu G, et al (2002) Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in Delta 48-50 DMD cells. Proc Natl Acad Sci U S A 99:9456-61.
De Clercq E, Eckstein F, Sternbach H, Merigan TC (1969) Interferon induction by and ribonuclease sensitivity of thiophosphate-substituted polyribonucleotides. Antimicrobial Agents Chemother 9:187-91.
De Luca A, Pierno S, Liantonio A, Conte Camerino D (2002) Pre-clinical trials in Duchenne dystrophy: what animal models can tell us about potential drug effectiveness. Neuromuscul Disord 12:S142-6.
de Visser M, Bakker E, Defesche JC, Bolhuis PA, van Ommen GJ (1990) An unusual variant of Becker muscular dystrophy. Ann Neurol 27:578-81.
Dean RT, Jessup W, Roberts CR (1984) Effects of exogenous amines on mammalian cells, with particular reference to membrane flow. Biochem J 217:27-40.
Deconinck AE, Rafael JA, Skinner JA, Brown SC, Potter AC, Metzinger L, Watt DJ, et al (1997) Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90:717-27.
DelloRusso C, Scott JM, Hartigan-O'Connor D, Salvatori G, Barjot C, Robinson AS, Crawford RW, et al (2002) Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin. Proc Natl Acad Sci U S A 99:12979-84. Epub 2002 Sep 23.
Den Dunnen JT (1996) The Leiden Muscular Dystrophy pages
den Dunnen JT, Bakker E, Breteler EG, Pearson PL, van Ommen GJ (1987) Direct detection of more than 50% of the Duchenne muscular dystrophy mutations by field inversion gels. Nature 329:640-2.
Den Dunnen JT, Grootscholten PM, Bakker E, Blonden LA, Ginjaar HB, Wapenaar MC, van Paassen HM, et al (1989) Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet 45:835-47
Den Dunnen JT, Grootscholten PM, Dauwerse JG, Walker AP, Monaco AP, Butler R, Anand R, et al (1992)
Reconstruction of the 2.4 Mb human DMD-gene by homologous YAC recombination. Hum Mol Genet 1:19-28.
Dennis CL, Tinsley JM, Deconinck AE, Davies KE (1996) Molecular and functional analysis of the utrophin promoter. Nucleic Acids Res 24:1646-52.
Derossi D, Chassaing G, Prochiantz A (1998) Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol 8:84-7.
Dickson G, Hill V, Graham IR (2002) Screening for antisense modulation of dystrophin pre-mRNA splicing. Neuromuscul Disord 12:S67-70.
Dickson G, Love DR, Davies KE, Wells KE, Piper TA, Walsh FS (1991) Human dystrophin gene transfer: production and expression of a functional recombinant DNA-based gene. Hum Genet 88:53-8.
Doench JG, Petersen JC, Sharp PA (2003) siRNAs can fucntion as miRNAs. Genes Dev 17: 438-42
Dolinsky LC, de Moura-Neto RS, Falcao-Conceicao DN (2002) DGGE analysis as a tool to identify point mutations, de novo mutations and carriers of the dystrophin gene. Neuromuscul Disord 12:845-8.
Dominski Z, Kole R (1993) Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides. Proc Natl Acad Sci U S A 90:8673-7
Dong JY, Fan PD, Frizzell RA (1996) Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum Gene Ther 7:2101-12.
Drachman DB, Toyka KV, Myer E (1974) Prednisone in Duchenne muscular dystrophy. Lancet 2:1409-12. D'Souza VN, Nguyen TM, Morris GE, Karges W, Pillers DA, Ray PN (1995) A novel dystrophin isoform is required for
normal retinal electrophysiology. Hum Mol Genet 4:837-42.
Dubowitz V (1991) Prednisone in Duchenne dystrophy. Neuromuscul Disord 1:161-3.
Dubowitz V (2000) Muscular Dystrophies. In: Sanders WB (ed) Muscle disorders in Childhood, London, pp 34-79 Dubrovsky AL, Angelini C, Bonifati DM, Pegoraro E, Mesa L (1998) Steroids in muscular dystrophy: where do we stand?
Neuromuscul Disord 8:380-4.
Dunant P, Walter MC, Karpati G, Lochmuller H (2003) Gentamicin fails to increase dystrophin expression in dystrophin-deficient muscle. Muscle Nerve 27:624-7.
Dunckley MG, Manoharan M, Villiet P, Eperon IC, Dickson G (1998) Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides. Hum Mol Genet 7:1083-90
Dunckley MG, Wells DJ, Walsh FS, Dickson G (1993) Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. Hum Mol Genet 2:717-23.
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-8.
Emery AE (2002) The muscular dystrophies. Lancet 359:687-95.
Emery AEE, M.L.H. (1995) The history of a genetic disease. Duchenne Muscular dystrophy or Meryon's disease. Royal Society of Medicine Press Limited, London
Emery AEH (1993) Duchenne muscular dystrophy. Oxford University Press, Oxford
England SB, Nicholson LV, Johnson MA, Forrest SM, Love DR, Zubrzycka-Gaarn EE, Bulman DE, et al (1990) Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature 343:180-2.
Errington SJ, Mann CJ, Fletcher S, Wilton SD (2003) Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene. J Gene Med 5:518-27.
Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG, Campbell KP (1990) Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345:315-9
Fabb SA, Wells DJ, Serpente P, Dickson G (2002) Adeno-associated virus vector gene transfer and sarcolemmal expression of a 144 kDa micro-dystrophin effectively restores the dystrophin-associated protein complex and inhibits myofibre degeneration in nude/mdx mice. Hum Mol Genet 11:733-41.
Fan Y, Maley M, Beilharz M, Grounds M (1996) Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve 19:853-60.
Fanin M, Danieli GA, Cadaldini M, Miorin M, Vitiello L, Angelini C (1995) Dystrophin-positive fibers in Duchenne dystrophy: origin and correlation to clinical course. Muscle Nerve 18:1115-20
Fanin M, Danieli GA, Vitiello L, Senter L, Angelini C (1992) Prevalence of dystrophin-positive fibers in 85 Duchenne muscular dystrophy patients. Neuromuscul Disord 2:41-5.
Fanin M, Freda MP, Vitiello L, Danieli GA, Pegoraro E, Angelini C (1996) Duchenne phenotype with in-frame deletion removing major portion of dystrophin rod: threshold effect for deletion size? Muscle Nerve 19:1154-60. Favre D, Cherel Y, Provost N, Blouin V, Ferry N, Moullier P, Salvetti A (2000) Hyaluronidase enhances recombinant
adeno-associated virus (rAAV)-mediated gene transfer in the rat skeletal muscle. Gene Ther 7:1417-20. Feener CA, Koenig M, Kunkel LM (1989) Alternative splicing of human dystrophin mRNA generates isoforms at the
carboxy terminus. Nature 338:509-11.
Feero WG, Li S, Rosenblatt JD, Sirianni N, Morgan JE, Partridge TA, Huang L, et al (1997) Selection and use of ligands for receptor-mediated gene delivery to myogenic cells. Gene Ther 4:664-74.
Felisari G, Martinelli Boneschi F, Bardoni A, Sironi M, Comi GP, Robotti M, Turconi AC, et al (2000) Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy. Neurology 55:559-64.
Fenichel GM, Florence JM, Pestronk A, Mendell JR, Moxley RT, 3rd, Griggs RC, Brooke MH, et al (1991) Long-term benefit from prednisone therapy in Duchenne muscular dystrophy. Neurology 41:1874-7.
Ferlini A, Sewry C, Melis MA, Mateddu A, Muntoni F (1999) X-linked dilated cardiomyopathy and the dystrophin gene. Neuromuscul Disord 9:339-46.
Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F (1998) Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528-30.
Ferrer A, Wells KE, Wells DJ (2000) Immune responses to dystropin: implications for gene therapy of Duchenne muscular dystrophy. Gene Ther 7:1439-46.
Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806-11.
Fisher R, Tinsley JM, Phelps SR, Squire SE, Townsend ER, Martin JE, Davies KE (2001) Non-toxic ubiquitous over-expression of utrophin in the mdx mouse. Neuromuscul Disord 11:713-21.
Flanigan KM, von Niederhausern A, Dunn DM, Alder J, Mendell JR, Weiss RB (2003) Rapid direct sequence analysis of the dystrophin gene. Am J Hum Genet 72:931-9. Epub 2003 Mar 11.
Flotte TR, Zeitlin PL, Reynolds TC, Heald AE, Pedersen P, Beck S, Conrad CK, et al (2003) Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study. Hum Gene Ther 14:1079-88.
Floyd SS, Jr., Clemens PR, Ontell MR, Kochanek S, Day CS, Yang J, Hauschka SD, et al (1998) Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles. Gene Ther 5:19-30. Fluiter K, ten Asbroek AL, de Wissel MB, Jakobs ME, Wissenbach M, Olsson H, Olsen O, et al (2003) In vivo tumor
growth inhibition and biodistribution studies of locked nucleic acid (LNA) antisense oligonucleotides. Nucleic Acids Res 31:953-62.
Francke U, Ochs HD, de Martinville B, Giacalone J, Lindgren V, Disteche C, Pagon RA, et al (1985) Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndrome. Am J Hum Genet 37:250-67. Franz WM, Muller M, Muller OJ, Herrmann R, Rothmann T, Cremer M, Cohn RD, et al (2000) Association of nonsense
mutation of dystrophin gene with disruption of sarcoglycan complex in X-linked dilated cardiomyopathy. Lancet 355:1781-5.
Friedman KJ, Kole J, Cohn JA, Knowles MR, Silverman LM, Kole R (1999) Correction of aberrant splicing of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by antisense oligonucleotides. J Biol Chem 274:36193-9.
Fukada S, Miyagoe-Suzuki Y, Tsukihara H, Yuasa K, Higuchi S, Ono S, Tsujikawa K, et al (2002) Muscle regeneration by reconstitution with bone marrow or fetal liver cells from green fluorescent protein-gene transgenic mice. J Cell Sci 115:1285-93.
Gait MJ (2003) Peptide-mediated cellular delivery of antisense oligonucleotides and their analogues. Cell Mol Life Sci 60:844-53.
Galvagni F, Cantini M, Oliviero S (2002) The utrophin gene is transcriptionally up-regulated in regenerating muscle. J Biol Chem 277:19106-13.
Galvagni F, Saad FA, Danieli GA, Miorin M, Vitiello L, Mostacciuolo ML, Angelini C (1994) A study on duplications of the dystrophin gene: evidence of a geographical difference in the distribution of breakpoints by intron. Hum Genet 94:83-7.
Gangopadhyay SB, Sherratt TG, Heckmatt JZ, Dubowitz V, Miller G, Shokeir M, Ray PN, et al (1992) Dystrophin in frameshift deletion patients with Becker muscular dystrophy. Am J Hum Genet 51:562-70.
Gaschen FP, Hoffman EP, Gorospe JR, Uhl EW, Senior DF, Cardinet GH, 3rd, Pearce LK (1992) Dystrophin deficiency causes lethal muscle hypertrophy in cats. J Neurol Sci 110:149-59.
Gaschen L, Lang J, Lin S, Ade-Damilano M, Busato A, Lombard CW, Gaschen FP (1999) Cardiomyopathy in dystrophin-deficient hypertrophic feline muscular dystrophy. J Vet Intern Med 13:346-56.
Gebski BL, Mann CJ, Fletcher S, Wilton SD (2003) Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle. Hum Mol Genet 12:1801-11.
Gieseler K, Grisoni K, Mariol MC, Segalat L (2002) Overexpression of dystrobrevin delays locomotion defects and muscle degeneration in a dystrophin-deficient Caenorhabditis elegans. Neuromuscul Disord 12:371-7. Gilbert R, Dudley RW, Liu AB, Petrof BJ, Nalbantoglu J, Karpati G (2003) Prolonged dystrophin expression and
functional correction of mdx mouse muscle following gene transfer with a helper-dependent (gutted) adenovirus-encoding murine dystrophin. Hum Mol Genet 12:1287-99.
Gilbert R, Nalbanoglu J, Tinsley JM, Massie B, Davies KE, Karpati G (1998) Efficient utrophin expression following adenovirus gene transfer in dystrophic muscle. Biochem Biophys Res Commun 242:244-7.
Gilbert R, Nalbantoglu J, Petrof BJ, Ebihara S, Guibinga GH, Tinsley JM, Kamen A, et al (1999) Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles. Hum Gene Ther 10:1299-310.
Gilchrist SC, Ontell MP, Kochanek S, Clemens PR (2002) Immune response to full-length dystrophin delivered to Dmd muscle by a high-capacity adenoviral vector. Mol Ther 6:359-68.
Gillard EF, Chamberlain JS, Murphy EG, Duff CL, Smith B, Burghes AH, Thompson MW, et al (1989) Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. Am J Hum Genet 45:507-20.
Gillis JM (2002) Multivariate evaluation of the functional recovery obtained by the overexpression of utrophin in skeletal muscles of the mdx mouse. Neuromuscul Disord 12:S90-4.
Ginjaar IB, Kneppers AL, v d Meulen JD, Anderson LV, Bremmer-Bout M, van Deutekom JC, Weegenaar J, et al (2000) Dystrophin nonsense mutation induces different levels of exon 29 skipping and leads to variable phenotypes within one BMD family [In Process Citation]. Eur J Hum Genet 8:793-6
Goldberg LR, Hausmanowa-Petrusewicz I, Fidzianska A, Duggan DJ, Steinberg LS, Hoffman EP (1998) A dystrophin missense mutation showing persistence of dystrophin and dystrophin-associated proteins yet a severe phenotype. Ann Neurol 44:971-6.
Goldstrohm AC, Greenleaf AL, Garcia-Blanco MA (2001) Co-transcriptional splicing of pre-messenger RNAs: considerations for the mechanism of alternative splicing. Gene 277:31-47.
Gollins H, McMahon J, Wells KE, Wells DJ, Romero NB, Benveniste O, Payan C, et al (2003) High-efficiency plasmid gene transfer into dystrophic muscle
Gorecki DC, Monaco AP, Derry JM, Walker AP, Barnard EA, Barnard PJ (1992) Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. Hum Mol Genet 1:505-10.
Gorman L, Suter D, Emerick V, Schumperli D, Kole R (1998) Stable alteration of pre-mRNA splicing patterns by modified U7 small nuclear RNAs. Proc Natl Acad Sci U S A 95:4929-34.
Gosselin LE, Barkley JE, Spencer MJ, McCormick KM, Farkas GA (2003) Ventilatory dysfunction in mdx mice: impact of tumor necrosis factor-alpha deletion. Muscle Nerve 28:336-43.
Graham MJ, Crooke ST, Monteith DK, Cooper SR, Lemonidis KM, Stecker KK, Martin MJ, et al (1998) In vivo distribution and metabolism of a phosphorothioate oligonucleotide within rat liver after intravenous administration. J Pharmacol Exp Ther 286:447-58.
Gramolini AO, Belanger G, Jasmin BJ (2001) Distinct regions in the 3' untranslated region are responsible for targeting and stabilizing utrophin transcripts in skeletal muscle cells. J Cell Biol 154:1173-83. Epub 2001 Sep 10. Granchelli JA, Avosso DL, Hudecki MS, Pollina C (1996) Cromolyn increases strength in exercised mdx mice. Res
Commun Mol Pathol Pharmacol 91:287-96.
Greenberg DS, Sunada Y, Campbell KP, Yaffe D, Nudel U (1994) Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice. Nat Genet 8:340-4.
Greener MJ, Sewry CA, Muntoni F, Roberts RG (2002) The 3'-untranslated region of the dystrophin gene - conservation and consequences of loss. Eur J Hum Genet 10:413-20.
Greenstein R, Reardon M, TS C (1977) An X-autosomal translocation in a girl with Duchenne muscular dystrophy, evidence for DMD gen localisation. Pediatr Res 11:475A
Gregorevic PB, M.J.; Allen, J.M.; Han, J.; Oakley, S.; Chamberlain J.S. (2004) Systemic Gene Transfer to Striated Muscles Using rAAV6 Vectors 7th annual meeting of the american society of gene therapy, Minneapolis (MN)
Griggs RC, Moxley RT, 3rd, Mendell JR, Fenichel GM, Brooke MH, Pestronk A, Miller JP, et al (1993) Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months). Neurology 43:520-7.
Grimm C, Stefanovic B, Schumperli D (1993) The low abundance of U7 snRNA is partly determined by its Sm binding site. Embo J 12:1229-38.
Grimm D, Kay MA (2003) From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Curr Gene Ther 3:281-304. Grounds MD, Torrisi J (2004) Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis.
Faseb J 18:676-82.
Gryaznov SC, J.-K. (1994) Oligodeoxyribonucleotide N3'-P5' phosphoramidates: Synthesis and hybridisation properties. J Am Chem Soc 116:3143-3144
Guan MX, Fischel-Ghodsian N, Attardi G (2000) A biochemical basis for the inherited susceptibility to aminoglycoside ototoxicity. Hum Mol Genet 9:1787-93.
Gussoni E, Bennett RR, Muskiewicz KR, Meyerrose T, Nolta JA, Gilgoff I, Stein J, et al (2002) Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. J Clin Invest 110:807-14.
Gussoni E, Blau HM, Kunkel LM (1997) The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat Med 3:970-7.
Hannon GJ (2002) RNA interference. Nature 418:244-51.
Harper SQ, Hauser MA, DelloRusso C, Duan D, Crawford RW, Phelps SF, Harper HA, et al (2002) Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat Med 8:253-61.
Hart KA, Hodgson S, Walker A, Cole CG, Johnson L, Dubowitz V, Bobrow M (1987) DNA deletions in mild and severe Becker muscular dystrophy. Hum Genet 75:281-5.
Hausen P, Stein H (1970) Ribonuclease H. An enzyme degrading the RNA moiety of DNA-RNA hybrids. Eur J Biochem 14:278-83.
Hayashi YK, Ogawa M, Tagawa K, Noguchi S, Ishihara T, Nonaka I, Arahata K (2001) Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology 57:115-21.
Heidenreich O, Gryaznov S, Nerenberg M (1997) RNase H-independent antisense activity of oligonucleotide N3 '--> P5 ' phosphoramidates. Nucleic Acids Res 25:776-80.
Helliwell TR, Man NT, Morris GE, Davies KE (1992) The dystrophin-related protein, utrophin, is expressed on the sarcolemma of regenerating human skeletal muscle fibres in dystrophies and inflammatory myopathies. Neuromuscul Disord 2:177-84.
Hermonat PL, Muzyczka N (1984) Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci U S A 81:6466-70.
Herweijer H, Wolff JA (2003) Progress and prospects: naked DNA gene transfer and therapy. Gene Ther 10:453-8. Highsmith WE, Burch LH, Zhou Z, Olsen JC, Boat TE, Spock A, Gorvoy JD, et al (1994) A novel mutation in the cystic
fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med 331:974-80.
Hodgson SV, Abbs S, Clark S, Manzur A, Heckmatt JZ, Dubowitz V, Bobrow M (1992) Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy, with special reference to mental ability. Neuromuscul Disord 2:269-76.
Hoffman EP, Brown RH, Jr., Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919-28
Hoffman EP, Fischbeck KH, Brown RH, Johnson M, Medori R, Loike JD, Harris JB, et al (1988) Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med 318:1363-8
Hoffman EP, Morgan JE, Watkins SC, Partridge TA (1990) Somatic reversion/suppression of the mouse mdx phenotype in vivo. J Neurol Sci 99:9-25.
Hofstra RM, Mulder IM, Vossen R, de Koning-Gans PA, Kraak M, Ginjaar IB, van der Hout AH, et al (2004) DGGE-based whole-gene mutation scanning of the dystrophin gene in Duchenne and Becker muscular dystrophy patients. Hum Mutat 23:57-66.
Hohenester E, Tisi D, Talts JF, Timpl R (1999) The crystal structure of a laminin G-like module reveals the molecular basis of alpha-dystroglycan binding to laminins, perlecan, and agrin. Mol Cell 4:783-92.
Hojo M, Morimoto T, Maluccio M, Asano T, Morimoto K, Lagman M, Shimbo T, et al (1999) Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 397:530-4.
Holder E, Maeda M, Bies RD (1996) Expression and regulation of the dystrophin Purkinje promoter in human skeletal muscle, heart, and brain. Hum Genet 97:232-9.
Howard PL, Dally GY, Ditta SD, Austin RC, Worton RG, Klamut HJ, Ray PN (1999) Dystrophin isoforms DP71 and DP427 have distinct roles in myogenic cells. Muscle Nerve 22:16-27.
Huard J, Akkaraju G, Watkins SC, Pike-Cavalcoli M, Glorioso JC (1997) LacZ gene transfer to skeletal muscle using a replication-defective herpes simplex virus type 1 mutant vector. Hum Gene Ther 8:439-52.
Huard J, Feero WG, Watkins SC, Hoffman EP, Rosenblatt DJ, Glorioso JC (1996) The basal lamina is a physical barrier to herpes simplex virus-mediated gene delivery to mature muscle fibers. J Virol 70:8117-23.
Huard J, Roy R, Bouchard JP, Malouin F, Richards CL, Tremblay JP (1992) Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions. Transplant Proc 24:3049-51. Hughes MD, Hussain M, Nawaz Q, Sayyed P, Akhtar S (2001) The cellular delivery of antisense oligonucleotides and
ribozymes. Drug Discov Today 6:303-315.
Hugnot JP, Gilgenkrantz H, Vincent N, Chafey P, Morris GE, Monaco AP, Berwald-Netter Y, et al (1992) Distal transcript of the dystrophin gene initiated from an alternative first exon and encoding a 75-kDa protein widely distributed in nonmuscle tissues. Proc Natl Acad Sci U S A 89:7506-10.
Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355:696-702. Ikezawa M, Cao B, Qu Z, Peng H, Xiao X, Pruchnic R, Kimura S, et al (2003) Dystrophin delivery in dystrophin-deficient
DMDmdx skeletal muscle by isogenic muscle-derived stem cell transplantation. Hum Gene Ther 14:1535-46. Im WB, Phelps SF, Copen EH, Adams EG, Slightom JL, Chamberlain JS (1996) Differential expression of dystrophin
isoforms in strains of mdx mice with different mutations. Hum Mol Genet 5:1149-53. Inui K, Okada S, Dickson G (1996) Gene therapy in Duchenne muscular dystrophy. Brain Dev 18:357-61. Ishigaki C, Patria SY, Nishio H, Yabe M, Matsuo M (1996) A Japanese boy with myalgia and cramps has a novel
in-frame deletion of the dystrophin gene. Neurology 46:1347-50.
Ittig D, Liu S, Renneberg D, Schumperli D, Leumann CJ, Bouliong E, Reber U (2004) Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA. Nucleic Acids Res 32:346-53. Print 2004.
Jablonka S, Rossoll W, Schrank B, Sendtner M (2000) The role of SMN in spinal muscular atrophy. J Neurol 247:I37-42. Jacobs PA, Hunt PA, Mayer M, Bart RD (1981) Duchenne muscular dystrophy (DMD) in a female with an X/autosome
translocation: further evidence that the DMD locus is at Xp21. Am J Hum Genet 33:513-8.
Jarrett HW, Foster JL (1995) Alternate binding of actin and calmodulin to multiple sites on dystrophin. J Biol Chem 270:5578-86.
Kafri T, Blomer U, Peterson DA, Gage FH, Verma IM (1997) Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 17:314-7.
Kameya S, Miyagoe Y, Nonaka I, Ikemoto T, Endo M, Hanaoka K, Nabeshima Y, et al (1999) alpha1-syntrophin gene disruption results in the absence of neuronal-type nitric-oxide synthase at the sarcolemma but does not induce muscle degeneration. J Biol Chem 274:2193-200.
Kapsa R, Quigley A, Lynch GS, Steeper K, Kornberg AJ, Gregorevic P, Austin L, et al (2001) In vivo and in vitro correction of the mdx dystrophin gene nonsense mutation by short-fragment homologous replacement. Hum Gene Ther 12:629-42.
Karpati G, Carpenter S, Morris GE, Davies KE, Guerin C, Holland P (1993) Localization and quantitation of the chromosome 6-encoded dystrophin-related protein in normal and pathological human muscle. J Neuropathol Exp Neurol 52:119-28.
Karras JG, Maier MA, Lu T, Watt A, Manoharan M (2001) Peptide nucleic acids are potent modulators of endogenous pre-mRNA splicing of the murine interleukin-5 receptor-alpha chain. Biochemistry 40:7853-9.
Karras JG, McKay RA, Dean NM, Monia BP (2000) Deletion of individual exons and induction of soluble murine interleukin-5 receptor-alpha chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing. Mol Pharmacol 58:380-7.
Kay MA, Manno CS, Ragni MV, Larson PJ, Couto LB, McClelland A, Glader B, et al (2000) Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet 24:257-61. Khurana TS, Davies KE (2003) Pharmacological strategies for muscular dystrophy. Nat Rev Drug Discov 2:379-90. Khurana TS, Watkins SC, Chafey P, Chelly J, Tome FM, Fardeau M, Kaplan JC, et al (1991) Immunolocalization and
developmental expression of dystrophin related protein in skeletal muscle. Neuromuscul Disord 1:185-94. Kichler A (2004) Gene transfer with modified polyethylenimines. J Gene Med 6:S3-10.
Kichler A, Chillon M, Leborgne C, Danos O, Frisch B (2002) Intranasal gene delivery with a polyethylenimine-PEG conjugate. J Control Release 81:379-88.
Kilimann MW, Pizzuti A, Grompe M, Caskey CT (1992) Point mutations and polymorphisms in the human dystrophin gene identified in genomic DNA sequences amplified by multiplex PCR. Hum Genet 89:253-8. Kinali M, Mercuri E, Main M, Muntoni F, Dubowitz V (2002) An effective, low-dosage, intermittent schedule of
prednisolone in the long-term treatment of early cases of Duchenne dystrophy. Neuromuscul Disord 12:S169-74.
Kingston HM, Sarfarazi M, Thomas NS, Harper PS (1984) Localisation of the Becker muscular dystrophy gene on the short arm of the X chromosome by linkage to cloned DNA sequences. Hum Genet 67:6-17.
Klein CJ, Coovert DD, Bulman DE, Ray PN, Mendell JR, Burghes AH (1992) Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers. Am J Hum Genet 50:950-9
Kleinsteuber K, Rocco P, Herrera L, Vainzof M, Birke ME, Yanez M, Flandes A, et al (2000) [Post exercise myalgias as presentation form of dystrophinopathy]. Rev Med Chil 128:772-7.
Knudsen H, Nielsen PE (1996) Antisense properties of duplex- and triplex-forming PNAs. Nucleic Acids Res 24:494-500. Kobayashi K, Nakahori Y, Miyake M, Matsumura K, Kondo-Iida E, Nomura Y, Segawa M, et al (1998) An ancient
retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 394:388-92. Kochanek S, Clemens PR, Mitani K, Chen HH, Chan S, Caskey CT (1996) A new adenoviral vector: Replacement of all
viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc Natl Acad Sci U S A 93:5731-6.
Koenig M, Beggs AH, Moyer M, Scherpf S, Heindrich K, Bettecken T, Meng G, et al (1989) The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet 45:498-506
Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM (1987) Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50:509-17.
Koenig M, Kunkel LM (1990) Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. J Biol Chem 265:4560-6.
Koenig M, Monaco AP, Kunkel LM (1988) The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53:219-26
Koike S, Schaeffer L, Changeux JP (1995) Identification of a DNA element determining synaptic expression of the mouse acetylcholine receptor delta-subunit gene. Proc Natl Acad Sci U S A 92:10624-8.
Krawczak M, Reiss J, Cooper DN (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90:41-54.
Kren BT, Bandyopadhyay P, Steer CJ (1998) In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides. Nat Med 4:285-90.
Kren BT, Parashar B, Bandyopadhyay P, Chowdhury NR, Chowdhury JR, Steer CJ (1999) Correction of the UDP-glucuronosyltransferase gene defect in the gunn rat model of crigler-najjar syndrome type I with a chimeric oligonucleotide. Proc Natl Acad Sci U S A 96:10349-54.
Kuhn H, Demidov VV, Nielsen PE, Frank-Kamenetskii MD (1999) An experimental study of mechanism and specificity of peptide nucleic acid (PNA) binding to duplex DNA. J Mol Biol 286:1337-45.
Kuivenhoven JA, Weibusch H, Pritchard PH, Funke H, Benne R, Assmann G, Kastelein JJ (1996) An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder (fish-eye disease). J Clin Invest 98:358-64.
Kunzelmann K, Legendre JY, Knoell DL, Escobar LC, Xu Z, Gruenert DC (1996) Gene targeting of CFTR DNA in CF epithelial cells. Gene Ther 3:859-67.
Kurreck J (2003) Antisense technologies. Improvement through novel chemical modifications. Eur J Biochem 270:1628-44.
Laing NG (1993) Molecular genetics and genetic couselling for Duchenne/Becker muscular dystrophy. In: Partridge TA (ed) Molecular and Cell Biology of Muscular Dystrophy. Chapman& Hall, London, pp 37-84
Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, et al (2001) Initial sequencing and analysis of the human genome. Nature 409:860-921.
Larsen HJ, Bentin T, Nielsen PE (1999) Antisense properties of peptide nucleic acid. Biochim Biophys Acta 1489:159-66.
Lebakken CS, Venzke DP, Hrstka RF, Consolino CM, Faulkner JA, Williamson RA, Campbell KP (2000) Sarcospan-deficient mice maintain normal muscle function. Mol Cell Biol 20:1669-77.
Lebedeva I, Stein CA (2001) Antisense oligonucleotides: promise and reality. Annu Rev Pharmacol Toxicol 41:403-19. Lederfein D, Levy Z, Augier N, Mornet D, Morris G, Fuchs O, Yaffe D, et al (1992) A 71-kilodalton protein is a major
product of the Duchenne muscular dystrophy gene in brain and other nonmuscle tissues. Proc Natl Acad Sci U S A 89:5346-50.
Lemaire C, Heilig R, Mandel JL (1988) The chicken dystrophin cDNA: striking conservation of the C-terminal coding and 3' untranslated regions between man and chicken. Embo J 7:4157-62.
Lemieux P, Guerin N, Paradis G, Proulx R, Chistyakova L, Kabanov A, Alakhov V (2000) A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle. Gene Ther 7:986-91.
Lenk U, Demuth S, Kraft U, Hanke R, Speer A (1993) Alternative splicing of dystrophin mRNA complicates carrier determination: report of a DMD family. J Med Genet 30:206-9.
Lenk U, Oexle K, Voit T, Ancker U, Hellner KA, Speer A, Hubner C (1996) A cysteine 3340 substitution in the dystroglycan-binding domain of dystrophin associated with Duchenne muscular dystrophy, mental retardation and absence of the ERG b-wave. Hum Mol Genet 5:973-5.
Levin AA (1999) A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides. Biochim Biophys Acta 1489:69-84.
Lewin B (2000) Genes. Oxford University Press, New York
Liang KW, Nishikawa M, Liu F, Sun B, Ye Q, Huang L (2004) Restoration of dystrophin expression in mdx mice by intravascular injection of naked DNA containing full-length dystrophin cDNA. Gene Ther 26:26 Lidov HG, Kunkel LM (1997) Dp140: alternatively spliced isoforms in brain and kidney. Genomics 45:132-9.
Lidov HG, Selig S, Kunkel LM (1995) Dp140: a novel 140 kDa CNS transcript from the dystrophin locus. Hum Mol Genet 4:329-35
Liechti-Gallati S, Koenig M, Kunkel LM, Frey D, Boltshauser E, Schneider V, Braga S, et al (1989) Molecular deletion patterns in Duchenne and Becker type muscular dystrophy. Hum Genet 81:343-8.
Liechty KW, MacKenzie TC, Shaaban AF, Radu A, Moseley AM, Deans R, Marshak DR, et al (2000) Human
mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6:1282-6.
Lim LE, Duclos F, Broux O, Bourg N, Sunada Y, Allamand V, Meyer J, et al (1995) Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat Genet 11:257-65.
Lin S, Burgunder JM (2000) Utrophin may be a precursor of dystrophin during skeletal muscle development. Brain Res Dev Brain Res 119:289-95.
Lindsay MA (2002) Peptide-mediated cell delivery: application in protein target validation. Curr Opin Pharmacol 2:587-94.
Liu F, Nishikawa M, Clemens PR, Huang L, Gollins H, McMahon J, Wells KE, et al (2001a) Transfer of full-length Dmd to the diaphragm muscle of Dmd(mdx/mdx) mice through systemic administration of plasmid DNA. Mol Ther 4:45-51.
Liu HX, Cartegni L, Zhang MQ, Krainer AR (2001b) A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet 27:55-8.
Liu L, Rice MC, Kmiec EB (2001c) In vivo gene repair of point and frameshift mutations directed by chimeric RNA/DNA oligonucleotides and modified single-stranded oligonucleotides. Nucleic Acids Res 29:4238-50.
Loh NY, Newey SE, Davies KE, Blake DJ (2000) Assembly of multiple dystrobrevin-containing complexes in the kidney. J Cell Sci 113:2715-24.
Loke SL, Stein CA, Zhang XH, Mori K, Nakanishi M, Subasinghe C, Cohen JS, et al (1989) Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci U S A 86:3474-8.
Love DR, Byth BC, Tinsley JM, Blake DJ, Davies KE (1993) Dystrophin and dystrophin-related proteins: a review of protein and RNA studies. Neuromuscul Disord 3:5-21.
Love DR, Flint TJ, Marsden RF, Bloomfield JF, Daniels RJ, Forrest SM, Gabrielli O, et al (1990) Characterization of deletions in the dystrophin gene giving mild phenotypes. Am J Med Genet 37:136-42.
Lu QL, Liang HD, Partridge T, Blomley MJ (2003b) Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage. Gene Ther 10:396-405.
Lu QL, Mann CJ, Lou F, Bou-Gharios G, Morris GE, Xue SA, Fletcher S, et al (2003c) Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse. Nat Med 6:6
Lu QL, Morris GE, Wilton SD, Ly T, Artem'yeva OV, Strong P, Partridge TA (2000) Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion. J Cell Biol 148:985-96
Lukacs GL, Haggie P, Seksek O, Lechardeur D, Freedman N, Verkman AS (2000) Size-dependent DNA mobility in cytoplasm and nucleus. J Biol Chem 275:1625-9.
Lynch GS, Hinkle RT, Chamberlain JS, Brooks SV, Faulkner JA (2001) Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old. J Physiol 535:591-600.
Maconochie MK, Simpkins AH, Damien E, Coulton G, Greenfield AJ, Brown SD (1996) The cysteine-rich and C-terminal domains of dystrophin are not required for normal costameric localization in the mouse. Transgenic Res 5:123-30.
Malhotra SB, Hart KA, Klamut HJ, Thomas NS, Bodrug SE, Burghes AH, Bobrow M, et al (1988) Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science 242:755-9.
Mann CJ, Honeyman K, Cheng AJ, Ly T, Lloyd F, Fletcher S, Morgan JE, et al (2001) Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse. Proc Natl Acad Sci U S A 98:42-7.
Mann CJ, Honeyman K, McClorey G, Fletcher S, Wilton SD (2002) Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy. J Gene Med 4:644-54.
Maquat LE (1995) When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells. Rna 1:453-65.
Mardirossian G, Lei K, Rusckowski M, Chang F, Qu T, Egholm M, Hnatowich DJ (1997) In vivo hybridization of technetium-99m-labeled peptide nucleic acid (PNA). J Nucl Med 38:907-13.
Marwick C (1998) First "antisense" drug will treat CMV retinitis. Jama 280:871.
Mathews DH, Sabina J, Zuker M, Turner DH (1999) Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J Mol Biol 288:911-40.
Matsumura K, Burghes AH, Mora M, Tome FM, Morandi L, Cornello F, Leturcq F, et al (1994a) Immunohistochemical analysis of dystrophin-associated proteins in Becker/Duchenne muscular dystrophy with huge in-frame deletions in the NH2-terminal and rod domains of dystrophin. J Clin Invest 93:99-105.
Matsumura K, Campbell KP (1994b) Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Muscle Nerve 17:2-15.
Matsumura K, Ervasti JM, Ohlendieck K, Kahl SD, Campbell KP (1992) Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 360:588-91.
Matsumura K, Nonaka I, Tome FM, Arahata K, Collin H, Leturcq F, Recan D, et al (1993) Mild deficiency of dystrophin-associated proteins in Becker muscular dystrophy patients having in-frame deletions in the rod domain of dystrophin. Am J Hum Genet 53:409-16.
Matsuo M (2004) DMD clinical trail using antisense oligonucleotides Monoco round table conference, Monaco (France) Matsuo M, Masumura T, Nakajima T, Kitoh Y, Takumi T, Nishio H, Koga J, et al (1990) A very small frame-shifting
deletion within exon 19 of the Duchenne muscular dystrophy gene. Biochem Biophys Res Commun 170:963-7.
Matsuo M, Masumura T, Nishio H, Nakajima T, Kitoh Y, Takumi T, Koga J, et al (1991) Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy kobe. J Clin Invest 87:2127-31.
Matzke M, Aufsatz W, Kanno T, Daxinger L, Papp I, Mette MF, Matzke AJ (2004) Genetic analysis of RNA-mediated transcriptional gene silencing. Biochim Biophys Acta 1677:129-41.
Mauro A (1961) Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 9:493-5.
McDouall RM, Dunn MJ, Dubowitz V (1990) Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy. J Neurol Sci 99:199-217.
Medori R, Brooke MH, Waterston RH (1989) Genetic abnormalities in Duchenne and Becker dystrophies: clinical correlations. Neurology 39:461-5.
Melis MA, Cau M, Muntoni F, Mateddu A, Galanello R, Boccone L, Deidda F, et al (1998) Elevation of serum creatine kinase as the only manifestation of an intragenic deletion of the dystrophin gene in three unrelated families. Europ J Paediatr Neurol 2:255-61.
Mendell JR, Kissel JT, Amato AA, King W, Signore L, Prior TW, Sahenk Z, et al (1995) Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N Engl J Med 333:832-8.
Mercatante DR, Mohler JL, Kole R (2002) Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents. J Biol Chem 277:49374-82.
Meryon E (1851) On fatty degeneration of the voluntary muscles: report of the Royal Medical and Chirugical Society. Lancet 2:588-589
Milasin J, Muntoni F, Severini GM, Bartoloni L, Vatta M, Krajinovic M, Mateddu A, et al (1996) A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Hum Mol Genet 5:73-9.
Minasi MG, Riminucci M, De Angelis L, Borello U, Berarducci B, Innocenzi A, Caprioli A, et al (2002) The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development 129:2773-83.
Mirabella M, Galluzzi G, Manfredi G, Bertini E, Ricci E, De Leo R, Tonali P, et al (1998) Giant dystrophin deletion associated with congenital cataract and mild muscular dystrophy. Neurology 51:592-5.
Mizuno Y, Nonaka I, Hirai S, Ozawa E (1993) Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects. J Neurol Sci 119:43-52.
Mizuno Y, Yoshida M, Nonaka I, Hirai S, Ozawa E (1994) Expression of utrophin (dystrophin-related protein) and dystrophin-associated glycoproteins in muscles from patients with Duchenne muscular dystrophy. Muscle Nerve 17:206-16.
Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM (1988) An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 2:90-5
Monaco AP, Bertelson CJ, Middlesworth W, Colletti CA, Aldridge J, Fischbeck KH, Bartlett R, et al (1985) Detection of deletions spanning the Duchenne muscular dystrophy locus using a tightly linked DNA segment. Nature 316:842-5.
Monaco AP, Neve RL, Colletti-Feener C, Bertelson CJ, Kurnit DM, Kunkel LM (1986) Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 323:646-50.
Morita K, Hasegawa C, Kaneko M, Tsutsumi S, Sone J, Ishikawa T, Imanishi T, et al (2002a) 2'-O,4'-C-ethylene-bridged nucleic acids (ENA): highly nuclease-resistant and thermodynamically stable oligonucleotides for antisense drug. Bioorg Med Chem Lett 12:73-6.
Morita K, Takagi M, Hasegawa C, Kaneko M, Tsutsumi S, Sone J, Ishikawa T, et al (2003a) Synthesis and properties of 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) as effective antisense oligonucleotides. Bioorg Med Chem 11:2211-26.
Morita K, Yamate K, Kurakata S, Abe K, Imanishi T, Koizumi M (2002b) Down-regulation of VEGF mRNA expression by 2'-O,4'-C-ethylene-bridged nucleic acid (ENA) antisense oligonucleotides and investigation of non-target gene expression. Nucleic Acids Res Suppl:99-100.
Morita K, Yamate K, Kurakata S, Watanabe K, Imanishi T, Koizumi M (2003b) 2'-O,4'-C-ethylene-bridged nucleic acid (ENA) for effective antisense formation. Nucleosides Nucleotides Nucleic Acids 22:1619-21.
Moser H (1984) Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention. Hum Genet 66:17-40. Mueller GM, O'Day T, Watchko JF, Ontell M (2002) Effect of injecting primary myoblasts versus putative muscle-derived
stem cells on mass and force generation in mdx mice. Hum Gene Ther 13:1081-90.
Muntoni F, Cau M, Ganau A, Congiu R, Arvedi G, Mateddu A, Marrosu MG, et al (1993) Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med 329:921-5.
Muntoni F, Fisher I, Morgan JE, Abraham D (2002) Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research. Neuromuscul Disord 12:S162-5.
Nahirney PC, Dow PR, Ovalle WK (1997) Quantitative morphology of mast cells in skeletal muscle of normal and genetically dystrophic mice. Anat Rec 247:341-9.
Nasevicius A, Ekker SC (2000) Effective targeted gene 'knockdown' in zebrafish. Nat Genet 26:216-20.
Nawrotzki R, Loh NY, Ruegg MA, Davies KE, Blake DJ (1998) Characterisation of alpha-dystrobrevin in muscle. J Cell Sci 111:2595-605.
Nebert DW (2002) Proposal for an allele nomenclature system based on the evolutionary divergence of haplotypes. Hum Mutat 20:463-72.
Nguyen TM, Ellis JM, Love DR, Davies KE, Gatter KC, Dickson G, Morris GE (1991) Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain cell lines. J Cell Biol 115:1695-700.
Nicholson LV, Davison K, Johnson MA, Slater CR, Young C, Bhattacharya S, Gardner-Medwin D, et al (1989) Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy. J Neurol Sci 94:137-46.
Nicholson LV, Johnson MA, Bushby KM, Gardner-Medwin D (1993) Functional significance of dystrophin positive fibres in Duchenne muscular dystrophy. Arch Dis Child 68:632-6.
Nico B, Frigeri A, Nicchia GP, Corsi P, Ribatti D, Quondamatteo F, Herken R, et al (2003) Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice. Glia 42:235-51.
Nicolas AL, Young CS (1994) Characterization of DNA end joining in a mammalian cell nuclear extract: junction formation is accompanied by nucleotide loss, which is limited and uniform but not site specific. Mol Cell Biol 14:170-80.
Nielsen PE, Egholm M, Berg RH, Buchardt O (1991) Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 254:1497-500.
Nigro V, de Sa Moreira E, Piluso G, Vainzof M, Belsito A, Politano L, Puca AA, et al (1996) Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. Nat Genet 14:195-8.
Nishio H, Takeshima Y, Narita N, Yanagawa H, Suzuki Y, Ishikawa Y, Minami R, et al (1994) Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter. J Clin Invest 94:1037-42.
Nobile C, Toffolatti L, Rizzi F, Simionati B, Nigro V, Cardazzo B, Patarnello T, et al (2002) Analysis of 22 deletion breakpoints in dystrophin intron 49. Hum Genet 110:418-21.
Noguchi S, McNally EM, Ben Othmane K, Hagiwara Y, Mizuno Y, Yoshida M, Yamamoto H, et al (1995) Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science 270:819-22.
Novina CD, Sharp PA (2004) The RNAi revolution. Nature 430: 161-4.
Obika SN, D.; Hari, Y.; Andoh, J.-I.; Morio, K.-I.; Doi, T.; Imanishi, T. (1998) Stability and structural features of the duplexes containing nucleoside analogues with fixed N-type conformation,
2'-O,4'-C-methyleneribonucleosides. Tetrahedron Lett. 39:5401-5404
Ohlendieck K, Campbell KP (1991a) Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J Cell Biol 115:1685-94.
Ohlendieck K, Ervasti JM, Matsumura K, Kahl SD, Leveille CJ, Campbell KP (1991b) Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle. Neuron 7:499-508.
Papahadjopoulos D, Allen TM, Gabizon A, Mayhew E, Matthay K, Huang SK, Lee KD, et al (1991) Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci U S A 88:11460-4.
Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM (1989) Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337:176-9.
Pasquini F, Guerin C, Blake D, Davies K, Karpati G, Holland P (1995) The effect of glucocorticoids on the accumulation of utrophin by cultured normal and dystrophic human skeletal muscle satellite cells. Neuromuscul Disord 5:105-14.
Passaquin AC, Renard M, Kay L, Challet C, Mokhtarian A, Wallimann T, Ruegg UT (2002) Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice. Neuromuscul Disord 12:174-82.
Passos-Bueno MR, Bakker E, Kneppers AL, Takata RI, Rapaport D, den Dunnen JT, Zatz M, et al (1992) Different mosaicism frequencies for proximal and distal Duchenne muscular dystrophy (DMD) mutations indicate difference in etiology and recurrence risk. Am J Hum Genet 51:1150-5.
Pastoret C, Sebille A (1995) mdx mice show progressive weakness and muscle deterioration with age. J Neurol Sci 129:97-105.
Pearce M, Blake DJ, Tinsley JM, Byth BC, Campbell L, Monaco AP, Davies KE (1993) The utrophin and dystrophin genes share similarities in genomic structure. Hum Mol Genet 2:1765-72.
Perkins KJ, Davies KE (2002) The role of utrophin in the potential therapy of Duchenne muscular dystrophy. Neuromuscul Disord 12:S78-89.
Pertea M, Lin X, Salzberg SL (2001) GeneSplicer: a new computational method for splice site prediction. Nucleic Acids Res 29:1185-90.
Peters MF, Sadoulet-Puccio HM, Grady MR, Kramarcy NR, Kunkel LM, Sanes JR, Sealock R, et al (1998) Differential membrane localization and intermolecular associations of alpha-dystrobrevin isoforms in skeletal muscle. J Cell Biol 142:1269-78.
Piccolo F, Roberds SL, Jeanpierre M, Leturcq F, Azibi K, Beldjord C, Carrie A, et al (1995) Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity. Nat Genet 10:243-5. Pillers DM, Bulman DE, Weleber RG, Sigesmund DA, Musarella MA, Powell BR, Murphey WH, et al (1993) Dystrophin
expression in the human retina is required for normal function as defined by electroretinography. Nat Genet 4:82-6.
Pislaru SV, Pislaru C, Kinnick RR, Singh R, Gulati R, Greenleaf JF, Simari RD (2003) Optimization of ultrasound-mediated gene transfer: comparison of contrast agents and ultrasound modalities. Eur Heart J 24:1690-8. Polakoff RJ, Morton AA, Koch KD, Rios CM (1998) The psychosocial and cognitive impact of Duchenne's muscular
dystrophy. Semin Pediatr Neurol 5:116-23.
